Genetics of hereditary diffuse gastric cancer: progress and future challenges

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Hereditary diffuse gastric cancer (HDGC) is a rare inherited cancer syndrome.
• Germline mutations in the E-cadherin gene are found in one-third of HDGC families.
• Current screening and chemoprevention options for HDGC are limited, leaving prophylactic gastrectomy as the primary management for mutation carriers.

Purpose of the Study:

• To address the diagnostic challenge posed by missense E-cadherin mutations in HDGC.
• To highlight the need for improved methods to determine the pathogenicity of missense mutations.
• To emphasize the importance of identifying novel genes implicated in diffuse gastric cancer beyond E-cadherin.

Main Methods:

• In silico analysis to predict the functional impact of missense mutations.
• In vitro functional studies to assess the pathogenicity of E-cadherin germline mutations.
• Review of existing literature on HDGC and E-cadherin mutations.

Main Results:

• Missense E-cadherin mutations, comprising 30% of reported mutations, present diagnostic difficulties.
• Functional and in silico studies are employed to infer pathogenicity in the absence of definitive clinical data.
• The majority of HDGC families do not harbor E-cadherin mutations, indicating other genetic factors.

Conclusions:

• Suboptimal management of HDGC patients with missense E-cadherin mutations necessitates further research.
• Identifying alternative genes is critical for understanding diffuse gastric cancer tumorigenesis.
• Advancing research into novel genetic targets is essential for improved HDGC diagnosis and treatment.